The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults
Status:
Completed
Trial end date:
2017-07-11
Target enrollment:
Participant gender:
Summary
This is a drug interaction study to evaluate the PF-06751979 at steady state on the
pharmacokinetics of oral midazolam single doses in fixed sequences including single dose
midazolam alone in period 1 followed by multiple doses of 100 mg PF-06751979 once a day for
11 days with single dose midazolam co-administered on Day 10 in period 2